Support our Foundation of Myology project
1722 news items
FOP: the day-to-day burden of the disease
On 31/10/2022
An international survey (NCT04665323), sponsored by the pharmaceutical company Ipsen, which develops palovarotene, and translated into 11 languages was available online between January and April…
A new mutation mechanism in SMA
On 31/10/2022
A few very rare cases of SMA are accompanied by complex genotypes. In this context, a team of French researchers has identified a novel mutation…
How to treat hypercholesterolemia in the context of Immune-mediated necrotizing myopathy?
On 28/10/2022
Immune-mediated necrotizing myopathy (IMNM) is very often linked to the use, whether prolonged or not, of statins. These cholesterol-lowering molecules are prescribed to nearly one…
Atypical forms of inclusion myositis are not so exceptional
On 27/10/2022
Inclusion myositis (or IBM for Inclusion body myositis) belongs to the group of inflammatory myopathies of autoimmune origin. US researchers from the Mayo Clinic compiled…
The value of myostatin measurement in the follow-up of inflammatory myopathies
On 27/10/2022
Measuring the activity of an inflammatory pathology such as inclusion myositis or autoimmune necrotizing myopathy is not easy. Researchers at the Institute of Myology in…
How American families affected by Duchenne or Becker muscular dystrophy feel about newborn screening
On 25/10/2022
In order to better understand the preferences of families regarding newborn screening, a questionnaire was completed by 66 families affected by Duchenne or Becker muscular…
DMD: positive results of Viltolarsen confirmed over two years
On 24/10/2022
May 2020, the publication of the results of the phase II clinical trial of Viltolarsen, in 16 boys with DMD aged 4 to 9 years,…
Brain dystrophin restoration improves memory in mdx mice
On 24/10/2022
In a study published in May 2022, two French teams succeeded in partially restoring dystrophin in certain brain regions of adult mdx mice, an animal…
A family observation of primary dysferlinopathy, an autosomal dominant genetic disorder
On 21/10/2022
Until now, dysferlin deficiencies reported in human pathology have all been inherited in the autosomal recessive mode. A few heterozygous individuals have been reported with…
A natural history study to better understand certain myopathies of mitochondrial origin
On 20/10/2022
Italian researchers studied 117 patients with mitochondrial pathologies with muscle expression. Three groups were formed (purely muscular mitochondriopathy, progressive external ophthalmoplegia [PEO] and mixed) The…
The concept of ‘actionable’ genes applied to myopathies
On 19/10/2022
A gene responsible for a given disease is said to be ‘actionable’ if it has direct or indirect therapeutic applications. This new concept in the…
Should carpal tunnel or cubital tunnel syndrome in CMT 1A and HNPP neuropathy be operated on?
On 19/10/2022
Nerve involvement in CMT 1A and HNPP neuropathy (tomacular or pressure palsy neuropathy) may increase the risk of carpal tunnel or cubital tunnel syndrome and…
The work of two researchers from the Institute awarded at the WMS
On 17/10/2022
Two researchers from the institute were awarded prizes for their work at the WMS 2022 conference held in Halifax, Canada, and online from 11 to…
M&M’s – Muscle Monday Seminar – 17 November – Pascale Bomont (France)
On 17/10/2022
Intermediate filaments: from mechanisms in giant axonal neuropathy to therapeutic perspectives for IF-pathies– November 17th, 2022 – 12:00 – 13:00 Pascale Bomont, PhD (ERC group leader, INSERM…
A new type of complication related to SMA gene therapy
On 17/10/2022
Italian clinicians report the case of a three-year-old child with SMA type 1 who developed hemophagocytic lymphohistiocytosis (HLH) three days after an intravenous injection of…
Low levels of anti-AAV9 and not age-dependent in adults with SMA
On 14/10/2022
German clinicians determined the level of anti-AAV9 antibodies in 69 adults with SMA type II and III. Using a threshold greater than 1/50 as an…
A new lead in the treatment of MELAS syndrome
On 14/10/2022
The MELAS syndrome is a mitochondrial disease with a partly neuromuscular expression and is related, in the vast majority of cases, to a point mutation…
A broad natural history study in myotonic dystrophies
On 13/10/2022
The American Myotonic Dystrophy Registry is, after the French DM-scope database, one of the most important registries for Steinert disease (DM1) and myotonic dystrophy type…
The first French series of patients with HINT1 neuropathy suggests a wider phenotypic and genotypic range
On 13/10/2022
Neuropathies or neuromyotonias related to the HINT1 gene are of recent discovery (2012). A group of French experts gathered under the aegis of FILNEMUS, the French…
A comparative study of two muscle biopsy techniques
On 12/10/2022
Australian rheumatologists conducted a study to compare the feasibility and diagnostic performance of two techniques of muscle tissue sampling: one based on open biopsy, usually…
